Literature DB >> 2238703

Species differences in metabolism of codeine: urinary excretion of codeine glucuronide, morphine-3-glucuronide and morphine-6-glucuronide in mice, rats, guinea pigs and rabbits.

K Oguri1, N Hanioka, H Yoshimura.   

Abstract

1. Metabolites of codeine were determined by use of h.p.l.c. in urine of male mice, rats, guinea pigs and rabbits injected with 10 mg codeine/kg subcutaneously. 2. In 24 h urines of these species, unchanged codeine, codeine glucuronide, free morphine, and morphine-3-glucuronide were as follows: mice, 6.8, 1.6, 0.8 and 7.6% dose; rats, 1.6, 0.2, 4.3 and 23.9% dose; guinea pigs, 1.6, 39.8, 0.2 and 1.6% dose; rabbits, 2.2, 24.5, 1.3 and 17.9% dose. Urinary excretion of morphine-6-glucuronide was 0.7% dose in guinea pigs, 1.9% in rabbits, and not detectable in mice and rats. Norcodeine was found only in the urine of mice. 3. These results indicate that codeine is metabolized in all four species by glucuronidation and by oxidative N- and O-demethylation, but the quantitative excretions of metabolites were quite different in different species.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2238703     DOI: 10.3109/00498259009046884

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  10 in total

1.  Analgesic and immunomodulatory effects of codeine and codeine 6-glucuronide.

Authors:  V Srinivasan; D Wielbo; J Simpkins; J Karlix; K Sloan; I Tebbett
Journal:  Pharm Res       Date:  1996-02       Impact factor: 4.200

2.  Dynamic vaccine blocks relapse to compulsive intake of heroin.

Authors:  Joel E Schlosburg; Leandro F Vendruscolo; Paul T Bremer; Jonathan W Lockner; Carrie L Wade; Ashlee A K Nunes; G Neil Stowe; Scott Edwards; Kim D Janda; George F Koob
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-06       Impact factor: 11.205

3.  The mixed kappa and delta opioid receptor agonist, MP1104, attenuates chemotherapy-induced neuropathic pain.

Authors:  Diana Vivian Atigari; Kelly Frances Paton; Rajendra Uprety; András Váradi; Amy Frances Alder; Brittany Scouller; John H Miller; Susruta Majumdar; Bronwyn Maree Kivell
Journal:  Neuropharmacology       Date:  2020-12-28       Impact factor: 5.250

Review 4.  Clinical pharmacology of analgesics assessed with human experimental pain models: bridging basic and clinical research.

Authors:  Bruno Georg Oertel; Jörn Lötsch
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

5.  Stable isotope-labelled morphine to study in vivo central and peripheral morphine glucuronidation and brain transport in tolerant mice.

Authors:  Ivan Weinsanto; Alexis Laux-Biehlmann; Jinane Mouheiche; Tando Maduna; François Delalande; Virginie Chavant; Florian Gabel; Pascal Darbon; Alexandre Charlet; Pierrick Poisbeau; Marc Lamshöft; Alain Van Dorsselaer; Sarah Cianferani; Marie-Odile Parat; Yannick Goumon
Journal:  Br J Pharmacol       Date:  2018-08-31       Impact factor: 8.739

6.  Pharmacokinetics, adverse effects and effects on thermal nociception following administration of three doses of codeine to horses.

Authors:  Heather K Knych; Kristen Stucker; Sophie R Gretler; Philip H Kass; Daniel S McKemie
Journal:  BMC Vet Res       Date:  2022-05-25       Impact factor: 2.792

Review 7.  Morphine-3-Glucuronide, Physiology and Behavior.

Authors:  Florian Gabel; Volodya Hovhannisyan; Abdel-Karim Berkati; Yannick Goumon
Journal:  Front Mol Neurosci       Date:  2022-05-12       Impact factor: 6.261

8.  Metabolism, pharmacokinetics and selected pharmacodynamic effects of codeine following a single oral administration to horses.

Authors:  Sophie R Gretler; Carrie J Finno; Daniel S McKemie; Philip H Kass; Heather K Knych
Journal:  Vet Anaesth Analg       Date:  2020-04-23       Impact factor: 1.648

9.  A pharmacokinetic-pharmacodynamic model of tolerance to morphine analgesia during infusion in rats.

Authors:  D M Ouellet; G M Pollack
Journal:  J Pharmacokinet Biopharm       Date:  1995-12

10.  Physiologically-based modelling in mice suggests an aggravated loss of clearance capacity after toxic liver damage.

Authors:  Arne Schenk; Ahmed Ghallab; Ute Hofmann; Reham Hassan; Michael Schwarz; Andreas Schuppert; Lars Ole Schwen; Albert Braeuning; Donato Teutonico; Jan G Hengstler; Lars Kuepfer
Journal:  Sci Rep       Date:  2017-07-24       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.